about
Interplay between the levels of estrogen and estrogen receptor controls the level of the granzyme inhibitor, proteinase inhibitor 9 and susceptibility to immune surveillance by natural killer cellsFocus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human gliomaMicroRNA targets in immune genes and the Dicer/Argonaute and ARE machinery componentsWhole-genome cancer analysis as an approach to deeper understanding of tumour biologyCancer immunoediting from immune surveillance to immune escapeTumor microenvironments, the immune system and cancer survivalDietary exposure to soy or whey proteins alters colonic global gene expression profiles during rat colon tumorigenesis.Immune checkpoint blockade therapy for bladder cancer treatmentTumor-Infiltrating Lymphocytes: A Promising Biomarker in Breast CancerCurrent status and perspectives in translational biomarker research for PD-1/PD-L1 immune checkpoint blockade therapyNK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy?Targeting microRNAs as key modulators of tumor immune responseHZE Radiation Non-Targeted Effects on the Microenvironment That Mediate Mammary CarcinogenesisUnderground Adaptation to a Hostile Environment: Acute Myeloid Leukemia vs. Natural Killer CellsParallel Aspects of the Microenvironment in Cancer and Autoimmune DiseaseCancer stem cells and immunoresistance: clinical implications and solutionsExercise in Regulation of Inflammation-Immune Axis Function in Cancer Initiation and ProgressionImmunotherapeutic approaches in biliary tract carcinoma: Current status and emerging strategiesA sequence-specific DNA binding small molecule triggers the release of immunogenic signals and phagocytosis in a model of B-cell lymphomaTargeting Transcriptional Regulators of CD8+ T Cell Dysfunction to Boost Anti-Tumor ImmunityCurcumin and tumor immune-editing: resurrecting the immune systemEnhancing Cancer Immunotherapy Via Activation of Innate ImmunityAdaptive Immune Resistance: How Cancer Protects from Immune AttackThe Evolution of T-cell Therapies for Solid MalignanciesThe Concept of Hormesis in Cancer Therapy - Is Less More?Genetic instability in the tumor microenvironment: a new look at an old neighborUnderstanding the function and dysfunction of the immune system in lung cancer: the role of immune checkpointsCancer vaccines: state of the art of the computational modeling approachesThe dual role of HLA-G in cancerTherapeutic cancer vaccines: past, present, and futureEffect and Molecular Mechanisms of Traditional Chinese Medicine on Regulating Tumor Immunosuppressive MicroenvironmentBioinformatics for cancer immunology and immunotherapyBeneficial autoimmunity at body surfaces - immune surveillance and rapid type 2 immunity regulate tissue homeostasis and cancerAre we causing the recurrence-impact of perioperative period on long-term cancer prognosis: Review of current evidence and practiceWays to enhance lymphocyte trafficking into tumors and fitness of tumor infiltrating lymphocytesReflections upon human cancer immune responsiveness to T cell-based therapyCharacteristics of tertiary lymphoid structures in primary cancersInflammatory networks and immune surveillance of pancreatic carcinomaImmunotherapy for brain cancer: recent progress and future promiseCombining radiotherapy and cancer immunotherapy: a paradigm shift
P2860
Q24293644-5BCDD1F1-0236-4C06-B21B-0C11D9785BABQ24615166-8391D911-7C56-48C8-84C1-560AFAE79444Q24648543-374A8D63-CCA1-4E21-8567-4298549F0E34Q24653972-A9BB8063-A761-4FB5-A117-F5001D3BFEF9Q24655415-D27ECCA4-5946-4D43-AA4B-DAECFCC8D905Q24797095-0B366F1D-120D-4F08-BDC6-1E362C9D8AF1Q24808665-206D2779-0AC6-4B2D-AAB3-917A4DEE8D57Q26744139-4A5904E2-4B98-4F14-AC1E-B859FC94F961Q26745446-BCC2D671-FC33-4A85-8DB6-20FB4CF66338Q26745516-BABEB822-EA6B-40D9-A139-813475A46ABFQ26746478-EB9A7E6B-6F9F-4451-BA54-ECAFE2DD10B1Q26746972-CB66140F-A5F0-4057-86BE-9C1F74F8A530Q26750868-A36ED3CB-4AFB-436A-89B9-E7C104990AE5Q26751011-E83D072F-37AD-4E29-98FD-853174F623C9Q26753174-C1570C3F-4996-4290-B905-49200B729D24Q26769757-93145B5D-2DA5-4ADB-9B2E-C12EE1C64FFCQ26775189-87214E35-DB68-42A4-B38F-0C9EE4F8B3CBQ26776184-ECD4EF53-38F8-4131-AAE9-95E545EC4786Q26780141-FCF20161-9CEB-4473-B1CD-509C5F393A37Q26782201-45EC0BC7-A2ED-4D53-95F8-06824FC455D2Q26783491-9D675290-9881-40DC-BC55-D19344AC8A97Q26796313-F237BA6F-BD3D-4DAA-A20D-14700C767DD0Q26798448-A56CF601-0FF9-4A46-B63D-C70500A54A36Q26799372-3BF1425E-2083-4A19-A9B6-8596C517EDF9Q26800519-945FDA4B-9C04-410F-86F5-1C2C73F5A37AQ26801374-9D3F6B4B-1E4F-48B6-A4C9-1D23E3DA49B9Q26801551-7CCD99E9-83A4-4F73-B6AE-0571142B9A2CQ26825044-C416A015-DE0C-4C43-835B-17211204E32BQ26860886-34924387-83E0-45A5-BA60-A6F67047D6E3Q26863283-376E3D9B-4087-4B93-9CE5-545E86768DBFQ26864045-4F10E67F-E6D5-4D1C-9DE6-C78AE1176102Q26864876-8B4D0B9D-6137-494D-99CB-4C6EFAC1BA37Q26865509-7F6F9EFB-14A2-4B35-9BEC-416914A53996Q26865763-88890BFC-9607-4BBC-911E-A21E3047DA62Q26991991-339DE096-2FC6-4577-A769-612A0AFFAD0CQ27004674-CE34B99E-C1CE-4DCD-940F-464326F3102FQ27012852-9F2F9569-E1DA-4F5D-A098-10DB5BA28E6FQ27013983-50302EA2-4CE0-497B-B999-1AD784E4D519Q27015881-985C57AE-50CA-423F-9A4D-71B5BB031D20Q27021428-1F218236-3C1E-4AF0-A74B-0038F5F7C003
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականին հրատարակուած գիտական յօդուած
@hyw
2004 թվականին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
The three Es of cancer immunoediting
@ast
The three Es of cancer immunoediting
@en
The three Es of cancer immunoediting
@nl
type
label
The three Es of cancer immunoediting
@ast
The three Es of cancer immunoediting
@en
The three Es of cancer immunoediting
@nl
prefLabel
The three Es of cancer immunoediting
@ast
The three Es of cancer immunoediting
@en
The three Es of cancer immunoediting
@nl
P2093
P3181
P1476
The three Es of cancer immunoediting
@en
P2093
Gavin P Dunn
Lloyd J Old
Robert D Schreiber
P304
P3181
P356
10.1146/ANNUREV.IMMUNOL.22.012703.104803
P407
P577
2004-01-01T00:00:00Z